Vanhoefer, U <br/><br/>
d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Dec 1996 
 - 1961-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Buthionine Sulfoximine--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Resistance, Multiple<br/>Drug Resistance, Neoplasm<br/>Drug Synergism<br/>Female<br/>Fibrosarcoma--drug therapy<br/>Genes, MDR--physiology<br/>Glutathione--blood<br/>Humans<br/>Immunohistochemistry<br/>Mice<br/>Mice, Nude<br/>Neoplasm Transplantation<br/>Tumor Cells, Cultured